LianBio Profile Avatar - Palmy Investing

LianBio

LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treat…

Biotechnology
US, Princeton [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

LianBio mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of LIAN's Analysis
CIK: 1831283 CUSIP: - ISIN: US53000N1081 LEI: - UEI: -
Secondary Listings
LIAN has no secondary listings inside our databases.